Thymalin

What is it?

Thymalin is the founding member of the Khavinson short-peptide bioregulator family — a body of research that began in 1970s Soviet military medicine at the Military Medical Academy in Leningrad, where researchers extracted tissue-specific peptide fractions from animal organs and observed bioactive effects when re-administered, especially in aged tissue. Vladimir Khavinson became the program’s central figure, and after 1991 the St. Petersburg Institute of Bioregulation and Gerontology became its institutional home.

Thymalin itself is the first-generation, extract-based product of that program: a polypeptide complex extracted from thymus tissue, not a synthesized single sequence like its “descendants” Thymagen and Vilon. Profiled by thepeptidelist.com under anti-aging (secondary use: immune), with an evidence tier of Moderate — 30 studies cited, 19 of them human. Thymalin is also one of the few Khavinson-family peptides with an actual clinical-use approval in Russia, alongside the related cortex peptide Cortexin.

What does it do in my body?

Claimed mechanism: thymus-derived peptides supporting T-cell development and immune-system function — restoring immune competence in the aging (involuting) thymus, the organ where T-cells mature.

This sits inside the broader Khavinson-family theoretical claim: that short tissue-derived peptides can cross cell and nuclear membranes, bind DNA promoter regions, and modulate transcription in a tissue-specific way — with Thymalin’s extract acting as a “regulatory signal” for the thymus. In-vitro work across the family supports the underlying nuclear-penetration mechanism: short Khavinson peptides have been shown to penetrate HeLa-cell nuclei and interact with DNA (Fedoreyeva et al. 2011, Biochemistry (Mosc), 22117547), and to drive heterochromatin decondensation and gene reactivation in lymphocytes from elderly subjects (Khavinson, Lezhava, Malinin 2004, Bull Exp Biol Med, 15085253).

How can it help me?

• Where the science stands: Deepest human record in the Khavinson family — 30 studies cited, 19 human — but zero RCTs; all Russian cohort work

The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.

Is it dangerous? What are the side effects?

The reported adverse-event profile in the Russian literature is mild and uncommon: occasional injection-site reactions, transient mild headache early in a cycle. No serious AEs documented at standard doses.

The real risk with Thymalin isn’t the molecule — it’s the supply chain. Khavinson-family peptides are the dominant gray-market counterfeit category in the peptide space. Most buyers are sourcing a Russian-school peptide from a forum link with no way to verify identity or purity, and counterfeit/mislabeled product is the most common failure mode for exactly these compounds — Thymalin included, and arguably more so given it’s a tissue-extract mixture rather than a single synthesizable sequence, which makes it harder to verify by casual means. Third-party COA verification matters more here than for almost any other peptide class.

Regulatory status: Thymalin is research_only in the US — not FDA-approved for human use, sold as a research compound, not eligible for compounding. It is not a controlled substance. Notably, Thymalin and the related cortex peptide Cortexin hold clinical-use approvals in Russia — that approval does not extend to the US.

Part 1 — How to reconstitute it

What's used: bacteriostatic water (sterile, preserved water the powder is mixed with) and a separate, larger reconstitution syringe used only for mixing — not the small syringe used for administration.

The exact bacteriostatic-water volume and resulting concentration for Thymalin are covered in the dosing notes and the deeper-science view. The right volume depends on the vial size.

How it's mixed

• The vial is tilted and the bacteriostatic water is added slowly down the inside glass wall — not squirted straight onto the powder.
• It is swirled gently to dissolve. It is never shaken — shaking can damage the peptide.
• The reconstituted vial is stored refrigerated and out of light.
• Reconstituted peptides are commonly used within a few weeks, inside the beyond-use window the source specifies — that window varies by peptide.

The free reconstitution calculator does the concentration math for any vial size and water volume, including the equivalent units on an insulin syringe.

Part 2 — Typical dosing

Educational context only — talk to a licensed medical provider before any protocol. What follows describes the doses and schedules most commonly reported in the research and by practitioners, shared so you can have an informed conversation. These compounds are sold for research use only, are not FDA-approved drugs, and this is not medical advice.

Administration as reported. Reported practice is subcutaneous administration (into the fat just under the skin) using a 0.3 mL U-100 insulin syringe, with sites rotated.

Educational purposes only — this reflects what Russian-school protocols and the peptide community actually use, stated plainly; it is not medical advice.

There is no Western-validated dosing protocol for Thymalin. What exists is the Khavinson-school cycle pattern shared across the whole family (see the Khavinson bioregulator family and Epithalon for the same cycle logic):

• Cycle structure: a short course — typically 10–20 consecutive days — followed by a long rest, repeated 2–3 times per year. The framework claims effects persist 2–3 months past the end of a cycle (an “epigenetic-like persistence” rationale for cycling instead of continuous dosing) — asserted by the Khavinson program, not independently confirmed.
• Thymalin specifically: historically given as a small intramuscular injection over a short in-clinic course in Russian protocols exact mg — because it’s a tissue extract rather than a single synthetic sequence, its dosing convention differs from the synthetic short peptides in the family (which run ~100–200 mcg/day).
• Storage: lyophilized powder is stable cold; once reconstituted with bacteriostatic water, refrigerate and use within roughly 28 days.

Because per-peptide human dose-finding data doesn’t exist for this family, treat every number above as community/Russian-protocol convergence, not a validated dose.

Turning milligrams into syringe units. On a U-100 syringe, 100 units = 1 mL, so 1 unit = 0.01 mL. At a concentration of C mg/mL, a dose of D mg = D ÷ C mL = (D ÷ C) × 100 units. Example: at 5 mg/mL, a 0.5 mg dose = 0.1 mL = 10 units. The exact units depend on the vial's mg and the water volume used.

What should I avoid combining — and what's synergistic?

Thymalin doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.

Where do people source this?